Safe switch to beta-interferon treatment of chronic hepatitis C after alpha-interferon-induced autoimmune thrombocytopenia

J Hepatol. 1996 Aug;25(2):270. doi: 10.1016/s0168-8278(96)80084-5.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Autoimmune Diseases / etiology*
  • Chronic Disease
  • Female
  • Hepatitis C / therapy*
  • Humans
  • Interferon-alpha / adverse effects*
  • Interferon-alpha / therapeutic use
  • Interferon-beta / therapeutic use*
  • Retreatment
  • Thrombocytopenia / etiology*

Substances

  • Interferon-alpha
  • Interferon-beta